Adagene Short Long Term Debt Total vs Other Liab Analysis

ADAG Stock

USD 2.64 0.44 14.29%

Adagene financial indicator trend analysis is way more than just evaluating Adagene prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Adagene is a good investment. Please check the relationship between Adagene Short Long Term Debt Total and its Other Liab accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Adagene. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

For more detail on how to invest in Adagene Stock please use our How to Invest in Adagene guide.

Short Long Term Debt Total vs Other Liab

Short Long Term Debt Total vs Other Liab Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Adagene Short Long Term Debt Total account and Other Liab. At this time, the significance of the direction appears to have pay attention.

The correlation between Adagene's Short Long Term Debt Total and Other Liab is -0.88. Overlapping area represents the amount of variation of Short Long Term Debt Total that can explain the historical movement of Other Liab in the same time period over historical financial statements of Adagene, assuming nothing else is changed. The correlation between historical values of Adagene's Short Long Term Debt Total and Other Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Short Long Term Debt Total of Adagene are associated (or correlated) with its Other Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Liab has no effect on the direction of Short Long Term Debt Total i.e., Adagene's Short Long Term Debt Total and Other Liab go up and down completely randomly.

Correlation Coefficient

-0.88

Relationship Direction	Negative
Relationship Strength	Significant

View All Relationships

Short Long Term Debt Total

Other Liab

Most indicators from Adagene's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Adagene current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Adagene. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

For more detail on how to invest in Adagene Stock please use our How to Invest in Adagene guide.At this time, Adagene's Enterprise Value Multiple is most likely to increase significantly in the upcoming years.

	2021	2022	2023	2024 (projected)
Depreciation And Amortization	1.1M	1.4M	1.2M	1.3M
Interest Income	76.2K	377.5K	4.3M	4.5M

Depreciation And Amortization Interest Income

Adagene fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Net Invested Capital	Property Plant And Equipment Gross
Total Assets		0.67	0.79	0.79	0.88	-0.61	0.86	0.49	0.65	-0.99	-0.81	0.91	0.99	0.32	0.01	0.01	1.0	0.47	0.74	0.8	-0.6	0.85	0.74	-0.42	0.88	0.43
Short Long Term Debt Total	0.67		0.94	0.94	0.66	-0.88	0.68	0.19	0.7	-0.64	-0.91	0.88	0.72	0.2	-0.02	0.04	0.69	-0.22	0.84	0.73	-0.62	0.84	0.76	-0.41	0.72	0.57
Other Current Liab	0.79	0.94		0.96	0.86	-0.74	0.87	0.48	0.71	-0.73	-0.93	0.95	0.79	0.21	0.11	-0.08	0.79	0.07	0.85	0.67	-0.82	0.87	0.91	-0.66	0.9	0.6
Total Current Liabilities	0.79	0.94	0.96		0.79	-0.75	0.79	0.48	0.85	-0.73	-0.88	0.93	0.8	0.27	0.05	-0.02	0.8	0.03	0.77	0.68	-0.72	0.9	0.83	-0.52	0.83	0.45
Total Stockholder Equity	0.88	0.66	0.86	0.79		-0.51	0.99	0.71	0.56	-0.81	-0.82	0.86	0.83	0.1	0.34	-0.32	0.88	0.48	0.68	0.66	-0.9	0.72	0.94	-0.8	1.0	0.59
Other Liab	-0.61	-0.88	-0.74	-0.75	-0.51		-0.57	0.09	-0.43	0.61	0.9	-0.75	-0.69	-0.2	0.11	-0.11	-0.63	0.39	-0.77	-0.86	0.43	-0.72	-0.63	0.15	-0.58	-0.73
Net Tangible Assets	0.86	0.68	0.87	0.79	0.99	-0.57		0.66	0.51	-0.8	-0.85	0.86	0.82	0.09	0.34	-0.32	0.87	0.41	0.71	0.7	-0.91	0.72	0.96	-0.79	1.0	0.67
Property Plant And Equipment Net	0.49	0.19	0.48	0.48	0.71	0.09	0.66		0.5	-0.38	-0.29	0.43	0.37	0.14	0.39	-0.36	0.48	0.62	0.13	0.04	-0.74	0.39	0.63	-0.75	0.68	0.08
Current Deferred Revenue	0.65	0.7	0.71	0.85	0.56	-0.43	0.51	0.5		-0.6	-0.53	0.69	0.64	0.19	0.07	-0.03	0.66	0.18	0.4	0.45	-0.45	0.71	0.51	-0.3	0.59	-0.07
Net Debt	-0.99	-0.64	-0.73	-0.73	-0.81	0.61	-0.8	-0.38	-0.6		0.77	-0.89	-0.99	-0.36	0.09	-0.1	-0.99	-0.47	-0.75	-0.81	0.49	-0.83	-0.65	0.3	-0.81	-0.39
Retained Earnings	-0.81	-0.91	-0.93	-0.88	-0.82	0.9	-0.85	-0.29	-0.53	0.77		-0.93	-0.84	-0.26	-0.02	0.0	-0.82	0.05	-0.89	-0.83	0.73	-0.86	-0.88	0.5	-0.86	-0.79
Accounts Payable	0.91	0.88	0.95	0.93	0.86	-0.75	0.86	0.43	0.69	-0.89	-0.93		0.93	0.4	-0.09	0.11	0.91	0.2	0.91	0.74	-0.7	0.96	0.84	-0.5	0.89	0.56
Cash	0.99	0.72	0.79	0.8	0.83	-0.69	0.82	0.37	0.64	-0.99	-0.84	0.93		0.35	-0.08	0.1	0.99	0.38	0.8	0.84	-0.54	0.88	0.71	-0.34	0.84	0.45
Non Current Assets Total	0.32	0.2	0.21	0.27	0.1	-0.2	0.09	0.14	0.19	-0.36	-0.26	0.4	0.35		-0.83	0.85	0.29	0.02	0.44	-0.02	0.06	0.62	0.06	0.24	0.12	0.02
Non Currrent Assets Other	0.01	-0.02	0.11	0.05	0.34	0.11	0.34	0.39	0.07	0.09	-0.02	-0.09	-0.08	-0.83		-1.0	0.02	0.22	-0.28	0.14	-0.52	-0.32	0.37	-0.64	0.32	0.18
Other Assets	0.01	0.04	-0.08	-0.02	-0.32	-0.11	-0.32	-0.36	-0.03	-0.1	0.0	0.11	0.1	0.85	-1.0		-0.01	-0.22	0.29	-0.14	0.5	0.35	-0.34	0.62	-0.29	-0.19
Cash And Short Term Investments	1.0	0.69	0.79	0.8	0.88	-0.63	0.87	0.48	0.66	-0.99	-0.82	0.91	0.99	0.29	0.02	-0.01		0.46	0.74	0.82	-0.6	0.84	0.75	-0.42	0.89	0.44
Net Receivables	0.47	-0.22	0.07	0.03	0.48	0.39	0.41	0.62	0.18	-0.47	0.05	0.2	0.38	0.02	0.22	-0.22	0.46		0.0	0.03	-0.25	0.11	0.18	-0.37	0.4	-0.22
Common Stock Total Equity	0.74	0.84	0.85	0.77	0.68	-0.77	0.71	0.13	0.4	-0.75	-0.89	0.91	0.8	0.44	-0.28	0.29	0.74	0.0		0.66	-0.54	0.87	0.71	-0.37	0.72	0.66
Common Stock Shares Outstanding	0.8	0.73	0.67	0.68	0.66	-0.86	0.7	0.04	0.45	-0.81	-0.83	0.74	0.84	-0.02	0.14	-0.14	0.82	0.03	0.66		-0.45	0.63	0.64	-0.22	0.7	0.63
Non Current Liabilities Total	-0.6	-0.62	-0.82	-0.72	-0.9	0.43	-0.91	-0.74	-0.45	0.49	0.73	-0.7	-0.54	0.06	-0.52	0.5	-0.6	-0.25	-0.54	-0.45		-0.54	-0.96	0.94	-0.9	-0.65
Other Current Assets	0.85	0.84	0.87	0.9	0.72	-0.72	0.72	0.39	0.71	-0.83	-0.86	0.96	0.88	0.62	-0.32	0.35	0.84	0.11	0.87	0.63	-0.54		0.7	-0.31	0.76	0.43
Other Stockholder Equity	0.74	0.76	0.91	0.83	0.94	-0.63	0.96	0.63	0.51	-0.65	-0.88	0.84	0.71	0.06	0.37	-0.34	0.75	0.18	0.71	0.64	-0.96	0.7		-0.83	0.96	0.74
Total Liab	-0.42	-0.41	-0.66	-0.52	-0.8	0.15	-0.79	-0.75	-0.3	0.3	0.5	-0.5	-0.34	0.24	-0.64	0.62	-0.42	-0.37	-0.37	-0.22	0.94	-0.31	-0.83		-0.78	-0.5
Net Invested Capital	0.88	0.72	0.9	0.83	1.0	-0.58	1.0	0.68	0.59	-0.81	-0.86	0.89	0.84	0.12	0.32	-0.29	0.89	0.4	0.72	0.7	-0.9	0.76	0.96	-0.78		0.62
Property Plant And Equipment Gross	0.43	0.57	0.6	0.45	0.59	-0.73	0.67	0.08	-0.07	-0.39	-0.79	0.56	0.45	0.02	0.18	-0.19	0.44	-0.22	0.66	0.63	-0.65	0.43	0.74	-0.5	0.62

Click cells to compare fundamentals

Adagene Account Relationship Matchups

Adagene fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	105.9M	84.3M	189.5M	152.4M	115.7M	128.7M
Short Long Term Debt Total	2.6M	8.0M	7.5M	28.0M	22.3M	12.9M
Other Current Liab	4.4M	8.6M	16.5M	22.5M	19.7M	14.5M
Total Current Liabilities	7.2M	16.1M	29.8M	55.1M	31.5M	27.5M
Total Stockholder Equity	(57.0M)	(89.4M)	156.6M	83.1M	70.6M	74.1M
Net Tangible Assets	(57.0M)	(89.4M)	156.6M	83.1M	95.6M	100.3M
Property Plant And Equipment Net	1.9M	2.1M	3.5M	3.0M	2.2M	2.8M
Current Deferred Revenue	993.4K	725.5K	5.5M	15.1M	52.9K	50.2K
Net Debt	(90.0M)	(67.2M)	(166.9M)	(115.8M)	(87.6M)	(92.0M)
Retained Earnings	(63.3M)	(105.7M)	(178.8M)	(258.8M)	(277.8M)	(263.9M)
Accounts Payable	712.7K	1.8M	3.3M	3.7M	3.1M	2.4M
Cash	92.5M	75.2M	174.4M	143.8M	109.9M	112.2M
Non Current Assets Total	2.0M	5.2M	3.6M	3.1M	2.3M	3.4M
Non Currrent Assets Other	(109.8K)	(4.1M)	69.3K	109.6K	84.9K	89.1K
Other Assets	87.2K	3.1M	69.3K	109.6K	1.0	0.95
Cash And Short Term Investments	100.5M	75.2M	174.4M	143.8M	109.9M	119.7M
Net Receivables	2.1M	132.4K	7.5M	619.4K	222.0K	210.9K
Common Stock Shares Outstanding	44.2M	35.1M	40.0M	43.3M	43.8M	44.1M
Liabilities And Stockholders Equity	105.9M	84.3M	189.5M	152.4M	115.7M	128.7M
Non Current Liabilities Total	155.7M	157.5M	3.1M	14.2M	13.7M	13.0M
Other Current Assets	1.2M	3.8M	4.1M	4.9M	3.3M	3.4M
Other Stockholder Equity	(147.6M)	(137.8M)	335.5M	342.7M	350.1M	367.6M
Total Liab	162.9M	173.7M	33.0M	69.3M	45.2M	77.3M
Net Invested Capital	(54.5M)	(81.4M)	164.0M	110.9M	92.5M	97.1M
Property Plant And Equipment Gross	1.9M	2.1M	3.5M	3.0M	8.9M	9.4M
Short Long Term Debt	1.0M	5.0M	4.5M	13.6M	8.4M	6.4M
Total Current Assets	103.9M	79.1M	186.0M	149.3M	113.4M	125.3M
Accumulated Other Comprehensive Income	(344.9K)	(351.0K)	(94.0K)	(849.3K)	(1.8M)	(1.7M)
Capital Stock	1.5K	1.9K	5.6K	5.5K	5.5K	4.0K
Net Working Capital	96.7M	63.0M	156.1M	94.2M	82.0M	97.8M
Short Term Debt	1.0M	5.0M	4.5M	13.8M	8.6M	6.5M
Common Stock	1.5K	1.9K	5.6K	5.5K	5.5K	4.0K
Property Plant Equipment	1.9M	2.1M	3.5M	3.0M	3.4M	2.9M

Currently Active Assets on Macroaxis

CRM	Salesforce
CRM	Salesforce
S	SentinelOne
V	Visa Class A
GOOG	Alphabet Inc Class C

When determining whether Adagene is a strong investment it is important to analyze Adagene's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Adagene's future performance. For an informed investment choice regarding Adagene Stock, refer to the following important reports:

How To Invest In Adagene

Details

Is Adagene Stock a good investment?

Details

What is Adagene's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Adagene. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

For more detail on how to invest in Adagene Stock please use our How to Invest in Adagene guide.

You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Adagene. If investors know Adagene will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Adagene listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.72)

Revenue Per Share

0.019

Quarterly Revenue Growth

(0.85)

Return On Assets

(0.20)

Return On Equity

(0.46)

The market value of Adagene is measured differently than its book value, which is the value of Adagene that is recorded on the company's balance sheet. Investors also form their own opinion of Adagene's value that differs from its market value or its book value, called intrinsic value, which is Adagene's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Adagene's market value can be influenced by many factors that don't directly affect Adagene's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Adagene's value and its price as these two are different measures arrived at by different means. Investors typically determine if Adagene is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Adagene's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Adagene Short Long Term Debt Total vs Other Liab Analysis

Short Long Term Debt Total vs Other Liab

Short Long Term Debt Total vs Other Liab Correlation Analysis

Correlation Coefficient

Short Long Term Debt Total

Other Liab

Adagene fundamental ratios Correlations

Adagene Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Adagene fundamental ratios Accounts

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Total Assets
Net Invested Capital	+ 1.0	Total Stockholder Equity
Net Invested Capital	+ 1.0	Net Tangible Assets
Cash	+ 0.99	Total Assets
Net Tangible Assets	+ 0.99	Total Stockholder Equity
Cash And Short Term Investments	+ 0.99	Cash

Other Assets	- 1.0	Non Currrent Assets Other
Cash And Short Term Investments	- 0.99	Net Debt
Cash	- 0.99	Net Debt
Net Debt	- 0.99	Total Assets
Other Stockholder Equity	- 0.96	Non Current Liabilities Total
Accounts Payable	- 0.93	Retained Earnings